Humoral and T-cell response to SARS-CoV-2 vaccination in patients with rheumatoid arthritis
Description
CONCLUSION: In this RA cohort vaccinated with homologous and heterologous regimens against COVID-19, two out of ten patients did not develop IgG anti-SARS-CoV-2, 70% presented neutralizing activity and 65% specific T-cell response. The use of BBIBP
